Effect of microRNA-21 blockade in human triple negative breast cancer allografts on progression and immune checkpoint proteins

被引：0
|
作者：
Jin, Yuan-Yuan
Desai, Vilas Shivaji
Castro, Miguel M.
Mitchell, Edith P.
Wickstrom, Eric
机构：
[1] Bound Therapeut LLC, Cherry Hill, NJ USA
[2] Thomas Jefferson Univ, Philadelphia, PA USA
[3] Biosynthesis Inc, Lewisville, TX USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA
[5] Sidney Kimmel Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13097
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Inhibiting glycolysis facilitated checkpoint blockade therapy for triple-negative breast cancer
    Chong Li
    Yu Tang
    Ruizhi Zhang
    Liang Shi
    Jianying Chen
    Peng Zhang
    Ning Zhang
    Wei Li
    Discover Oncology, 16 (1)
  • [22] Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
    David J Klinke
    Breast Cancer Research, 16
  • [23] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
    Qureshi, Sadaf
    Chan, Nancy
    George, Mridula
    Ganesan, Shridar
    Toppmeyer, Deborah
    Omene, Coral
    BIOMARKER INSIGHTS, 2022, 17
  • [24] Is immune checkpoint modulation a potential therapeutic option in triple negative breast cancer?
    Klinke, David J., II
    BREAST CANCER RESEARCH, 2014, 16 (06):
  • [25] CD47 BLOCKADE MODULATES IMMUNOSUPPRESSIVE CHECKPOINT MOLECULES AND CELLULAR METABOLISM TO SENSITIZE TRIPLE-NEGATIVE BREAST CANCER TUMORS TO IMMUNE CHECKPOINT BLOCKADE THERAPY
    Stirling, Elizabeth
    Wilson, Adam
    Cook, Katherine
    Thomas, Alexandra
    Triozzi, Pierre
    Soto-Pantoja, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A646 - A646
  • [26] Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression
    Seager, R. J.
    Pabla, Sarabjot
    Gandhi, Shipra
    Senosain, Maria-Fernanda
    Parikh, Hardik
    Van Roey, Erik
    Gao, Shuang
    Pulivendula, Yamuna
    DePietro, Paul
    Nesline, Mary K.
    Dash, Durga P.
    Conroy, Jeffrey M.
    Hastings, Stephanie B.
    Strickland, Kyle C.
    Previs, Rebecca A.
    Severson, Eric A.
    Caveney, Brian
    Jensen, Taylor J.
    Ramkissoon, Shakti H.
    Ko, Heidi Chwan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] ZNF689 deficiency promotes intratumor heterogeneity and resistance to immune checkpoint blockade in triple-negative breast cancer
    Ge, Li-Ping
    Jin, Xi
    Di, Gen-Hong
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    CANCER RESEARCH, 2023, 83 (05)
  • [28] ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance
    Xu, Chao
    Xie, Yongjie
    Xie, Peng
    Li, Jianming
    Tong, Zhongsheng
    Yang, Yanfang
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [29] ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance
    Chao Xu
    Yongjie Xie
    Peng Xie
    Jianming Li
    Zhongsheng Tong
    Yanfang Yang
    Discover Oncology, 14
  • [30] Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
    Vito, Alyssa
    Salem, Omar
    El-Sayes, Nader
    MacFawn, Ian P.
    Portillo, Ana L.
    Milne, Katy
    Harrington, Danielle
    Ashkar, Ali A.
    Wan, Yonghong
    Workenhe, Samuel T.
    Nelson, Brad H.
    Bruno, Tullia C.
    Mossman, Karen L.
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
12345